The invention relates to compounds of Formula (0):
wherein Q, A
1
-A
8
, R
4
and R
5
and each has the meaning as described herein.
Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.